Literature DB >> 8226744

Expression of the extracellular domain of the rat liver prolactin receptor and its interaction with ovine prolactin.

K P Hooper1, R Padmanabhan, K E Ebner.   

Abstract

A clone of the extracellular domain of the rat liver prolactin receptor was generated by the RNA-based polymerase chain reaction, and the NH2-terminal 210 amino acids were expressed in HeLa cells using a vaccinia virus/T7 hybrid expression system. The protein was isolated from serum-free culture medium directly by chromatography on an ovine prolactin affinity column and yielded approximately 1.5 mg of protein/liter of suspension culture. The extracellular domain of the rat prolactin receptor inhibited the ovine prolactin-dependent mitogenesis of rat lymphoma Nb2 cells with an IC50 of 7.1 pM and bound 125I-labeled ovine prolactin with a Kd of 1.21 +/- 0.19 nM. In contrast, the binding of the 125I-labeled extracellular domain to ovine prolactin exhibited positive cooperativity with a Hill coefficient of 1.73. High pressure gel filtration chromatography was used to demonstrate the formation of a complex consisting of one molecule of ovine prolactin and two molecules of the extracellular domain of the rat prolactin receptor. Complex formation occurred with human growth hormone, but not with ovine growth hormone, a non-lactogen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226744

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Recombinant analogues of prolactin, growth hormone, and placental lactogen: correlations between physical structure, binding characteristics, and activity.

Authors:  A Gertler
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

2.  Obligate ordered binding of human lactogenic cytokines.

Authors:  Jeffery L Voorhees; Charles L Brooks
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

3.  Immunoreactive prolactins of the neurohypophyseal system display actions characteristic of prolactin and 16K prolactin.

Authors:  F J López-Gómez; L Torner; S Mejía; G M de la Escalera; C Clapp
Journal:  Endocrine       Date:  1995-08       Impact factor: 3.633

4.  Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy.

Authors:  K D O'Neal; M V Chari; C H Mcdonald; R G Cook; L Y Yu-Lee; J D Morrisett; W T Shearer
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

5.  Activation and inhibition of erythropoietin receptor function: role of receptor dimerization.

Authors:  S S Watowich; D J Hilton; H F Lodish
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

Review 6.  Molecular mechanisms of prolactin and its receptor.

Authors:  Charles L Brooks
Journal:  Endocr Rev       Date:  2012-05-10       Impact factor: 19.871

Review 7.  Prolactin receptor antagonists.

Authors:  C B Kuo; D Coss; A M Walker
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

8.  Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity.

Authors:  W S Alexander; D Metcalf; A R Dunn
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.